Effects of KCNQ1 Polymorphisms on the Therapeutic Efficacy of Oral Antidiabetic Drugs in Chinese Patients With Type 2 Diabetes

Clinical Pharmacology & Therapeutics ◽

10.1038/clpt.2010.351 ◽

2011 ◽

Vol 89 (3) ◽

pp. 437-442 ◽

Author(s):

W Yu ◽

C Hu ◽

R Zhang ◽

C Wang ◽

W Qin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Therapeutic Efficacy ◽

Antidiabetic Drugs ◽

Chinese Patients ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text

A variant of PSMD6 is associated with the therapeutic efficacy of oral antidiabetic drugs in Chinese type 2 diabetes patients

Scientific Reports ◽

10.1038/srep10701 ◽

2015 ◽

Vol 5 (1) ◽

Author(s):

Miao Chen ◽

Cheng Hu ◽

Rong Zhang ◽

Feng Jiang ◽

Jie Wang ◽

...

Keyword(s):

Type 2 Diabetes ◽

Therapeutic Efficacy ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic ◽

Diabetes Patients

Download Full-text

Glargine insulin/gliclazide MR combination therapy is more effective than premixed insulin monotherapy in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs

Diabetes/Metabolism Research and Reviews ◽

10.1002/dmrr.2661 ◽

2015 ◽

Vol 31 (7) ◽

pp. 725-733 ◽

Author(s):

Jian Zhou ◽

Fenping Zheng ◽

Xiaohui Guo ◽

Huazhang Yang ◽

Muxun Zhang ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Antidiabetic Drugs ◽

Chinese Patients ◽

Oral Antidiabetic Drugs ◽

Premixed Insulin ◽

Glargine Insulin ◽

Oral Antidiabetic

Download Full-text

Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study

Diabetes Therapy ◽

10.1007/s13300-017-0260-9 ◽

2017 ◽

Vol 8 (3) ◽

pp. 623-624

Author(s):

Yujing Jin ◽

Xiaowei Sun ◽

Xichen Zhao ◽

Tiehong Zhu

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Basal Insulin ◽

Antidiabetic Drugs ◽

Chinese Patients ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text

Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study

Diabetes Therapy ◽

10.1007/s13300-017-0247-6 ◽

2017 ◽

Vol 8 (3) ◽

pp. 611-621

Author(s):

Yujing Jin ◽

Xiaowei Sun ◽

Xichen Zhao ◽

Tiehong Zhu

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Basal Insulin ◽

Antidiabetic Drugs ◽

Chinese Patients ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text

Abstract #292 Efficacy of Hydroxychloroquine when added in Subjects with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Basal Insulin and Two Other Oral Antidiabetic Drugs

Endocrine Practice ◽

10.1016/s1530-891x(20)46636-4 ◽

2019 ◽

Vol 25 ◽

pp. 119-120

Author(s):

Arjun Baidya ◽

Ajay Chhabra

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Basal Insulin ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text

2224-PUB: Comparative Effectiveness of Second-Line Initiation of Basal Insulin Therapy vs. Oral Antidiabetic Drugs Added to Metformin among Patients with Type 2 Diabetes in Taiwan

Diabetes ◽

10.2337/db19-2224-pub ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 2224-PUB

Author(s):

PIN-HAO CHEN ◽

SHIHCHEN KUO ◽

HUANG-TZ OU

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Comparative Effectiveness ◽

Basal Insulin ◽

Antidiabetic Drugs ◽

Second Line ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text

Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)

Diabetes & Metabolism ◽

10.1016/j.diabet.2019.101117 ◽

2020 ◽

Vol 46 (2) ◽

pp. 100-109 ◽

Author(s):

M.S. Capehorn ◽

A.-M. Catarig ◽

J.K. Furberg ◽

A. Janez ◽

H.C. Price ◽

...

Keyword(s):

Type 2 Diabetes ◽

Antidiabetic Drugs ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text

Insulin glargine in combination with oral antidiabetic drugs as a cost-equivalent alternative to conventional insulin therapy in type 2 diabetes mellitus

Wiener klinische Wochenschrift ◽

10.1007/s00508-005-0429-5 ◽

2005 ◽

Vol 117 (17) ◽

pp. 593-598 ◽

Author(s):

Monika Lechleitner ◽

Michael Roden ◽

Eva Haehling ◽

Markus Mueller

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Insulin Therapy ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Conventional Insulin Therapy ◽

Oral Antidiabetic

Download Full-text

Albiglutide, a weekly GLP-1 receptor agonist, improves glycemic parameters in Japanese patients with type 2 diabetes over 1 year when added to single oral antidiabetic drugs

Current Medical Research and Opinion ◽

10.1080/03007995.2016.1261817 ◽

2016 ◽

Vol 33 (3) ◽

pp. 431-438 ◽

Author(s):

Inaha Okuda ◽

Timothy H. Wilson ◽

Lin Yue ◽

Hiromu Nakajima ◽

Molly C. Carr ◽

...

Keyword(s):

Type 2 Diabetes ◽

Receptor Agonist ◽

Japanese Patients ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text

CO033. EFFECTIVENESS AND SAFETY OF VILDAGLIPTIN COMPARED WITH OTHER ORAL ANTIDIABETIC DRUGS IN PATIENTS WITH TYPE 2 DIABETES (EDGE): RESULTS FROM PORTUGAL

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo ◽

10.1016/s1646-3439(12)70043-3 ◽

2012 ◽

Vol 7 (2) ◽

pp. 75

Author(s):

M. Marcelino ◽

J. Jácome de Castro ◽

C. Mathieu ◽

G. Bader

Keyword(s):

Type 2 Diabetes ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text